Post Reply
141-160 of 187
Dow Jones and Nasdaq good rebounce!
Sold 34,000 at 0.031
Sold 50,000 at 0.032
Sold 16,000 at 0.033.
Left 100,000 to sell haha. I tot can open 0.04 lei sian.
Sold 50,000 at 0.032
Sold 16,000 at 0.033.
Left 100,000 to sell haha. I tot can open 0.04 lei sian.
Singapore Edev' s value in DSS will be realised if Impact BioMedical can successfully list in US which is their plan.
SmallSmall ( Date: 16-Mar-2020 08:37) Posted:
|
Financial Effects on the NTA per Share of the Group
Before Completion of the Proposed Share Swap. After completion of the Proposed Share Swap
2.36 8.69
Before Completion of the Proposed Share Swap. After completion of the Proposed Share Swap
1.00 5.65
when will this happen?
Before Completion of the Proposed Share Swap. After completion of the Proposed Share Swap
2.36 8.69
Before Completion of the Proposed Share Swap. After completion of the Proposed Share Swap
1.00 5.65
when will this happen?
Good opportunity does not come very often, grab it.
Chiong ah ! $0.035 later......
PROPOSED US$50 MILLION SHARE SWAP
ENTRY INTO LEGALLY BINDING TERM SHEET
The gain on disposal after completion of the disposal of the Sale Shares to DSS BioHealth amounts
to approximately S$73.63 million (equivalent to approximately US$52.55 million)
The Consideration is US$50,000,000 (equivalent to approximately S$70.20 million) which
represents approximately 201.06% of the Company&rsquo s market capitalisation of approximately
S$34.92 million on 11 March 2020, being the last full market day on which trades were done
preceding the date of the Term Sheet. The Company&rsquo s market capitalisation was determined
by multiplying the number of shares in issue (1,163,934,284 shares) by the weighted average
price of such shares transacted on 11 March 2020 (S$0.030).
ENTRY INTO LEGALLY BINDING TERM SHEET
The gain on disposal after completion of the disposal of the Sale Shares to DSS BioHealth amounts
to approximately S$73.63 million (equivalent to approximately US$52.55 million)
The Consideration is US$50,000,000 (equivalent to approximately S$70.20 million) which
represents approximately 201.06% of the Company&rsquo s market capitalisation of approximately
S$34.92 million on 11 March 2020, being the last full market day on which trades were done
preceding the date of the Term Sheet. The Company&rsquo s market capitalisation was determined
by multiplying the number of shares in issue (1,163,934,284 shares) by the weighted average
price of such shares transacted on 11 March 2020 (S$0.030).
gregtan123 ( Date: 16-Mar-2020 07:58) Posted:
|
The gain on disposal after completion of the disposal of the Sale Shares to DSS BioHealth amounts to approximately S$73.63 million (equivalent to approximately US$52.55 million).
That is even more than SED?
That is even more than SED?
DSS close 17 cents. Pennies cannot sustain in US market.
gregtan123 ( Date: 13-Mar-2020 20:41) Posted:
|
Give u a better good news. SED is getting shares in lieu of payment. the shares exercise price is 0.216. now is 0.2795. yesterday high was 0.52. it 3.2x yesterday. Also why they bhave NOT announced? How come I as an investor know more than their insider/sponsor? This people never do their job.
SmallSmall ( Date: 13-Mar-2020 19:52) Posted:
|
Should be $0.05+current price of $0.03= $0.08 haha
gregtan123 ( Date: 13-Mar-2020 17:06) Posted:
|
haha thanks for the calculation. Can Monday open 0.05?
SmallSmall ( Date: 13-Mar-2020 16:44) Posted:
|
What is Asia phon?
ruready ( Date: 13-Mar-2020 11:39) Posted:
|
Singapore EDev paid-up capital 1,163,934,000. Assuming capped purchase price of US$50 mil, that will translate to S$0.057 per Singapore Edev assuming Impact Bio is debt free.
Wow ! Chiong ah!
Wow ! Chiong ah!
gregtan123 ( Date: 13-Mar-2020 13:22) Posted:
|
I caused the Trading Halt. Here' s the News (it was released in the USA yesterday). The share of the Buyer (DSS) more than doubled! I wrote to SGX and the Company, and the Sponsor then they reply then got halted! This morning I bought 150,000 at 0.028/0.029. Here' s the News:
Document Security Systems, Inc. (DSS) (NYSE: DSS) today announced that it has entered into a binding term sheet to (&ldquo Term Sheet&rdquo ) acquire Impact Biomedical, Inc. (IMPACT), a company engaged in the development and marketing of biohealth security technologies, in a proposed share exchange transaction with a purchase price capped at $50 million, subject to completion of due diligence and an independent valuation. According to the terms of the Term Sheet between the parties, DSS will issue up to 14.5 M shares of common stock and a perpetual convertible preferred stock to which DSS will have certain customary rights and requirements, including appointing members of the Board of Directors of IMPACT. The preferred stock will be convertible at $0.216 per share and have a 19.9% blocker.
https://www.streetinsider.com/Corporate+News/Document+Security+Systems+(DSS)+Announces+LOI+to+Acquire+Impact+Biomedical+Inc./16607527.html
Here' s my EMAIL to the Sponsor and the Sponsor Reply:
My email:
Hi SED, Mr Tang (sponsor of SED) as well SGX,
His reply:
Dear XXX
Thank you for the information.
We have followed up with the Company on this matter.
Document Security Systems, Inc. (DSS) (NYSE: DSS) today announced that it has entered into a binding term sheet to (&ldquo Term Sheet&rdquo ) acquire Impact Biomedical, Inc. (IMPACT), a company engaged in the development and marketing of biohealth security technologies, in a proposed share exchange transaction with a purchase price capped at $50 million, subject to completion of due diligence and an independent valuation. According to the terms of the Term Sheet between the parties, DSS will issue up to 14.5 M shares of common stock and a perpetual convertible preferred stock to which DSS will have certain customary rights and requirements, including appointing members of the Board of Directors of IMPACT. The preferred stock will be convertible at $0.216 per share and have a 19.9% blocker.
https://www.streetinsider.com/Corporate+News/Document+Security+Systems+(DSS)+Announces+LOI+to+Acquire+Impact+Biomedical+Inc./16607527.html
Here' s my EMAIL to the Sponsor and the Sponsor Reply:
My email:
Hi SED, Mr Tang (sponsor of SED) as well SGX,
I believe there is a Material Transaction regarding the Wholly-Owned Subsidiary of SED, Impact Biomedical, Inc.
This has caused the Company acquiring Impact price to double. I believe that there is an obligation to announce this on SGX?
His reply:
Dear XXX
Thank you for the information.
We have followed up with the Company on this matter.
Regards,
Tang Yeng Yuen
| Corporate Finance | Hong Leong Finance Limited
Co. Registration No.: 196100003D | www.hlf.com.sg
16 Raffles Quay #01-05 Hong Leong Building Singapore 048581
Direct: (65) 6415-9887 | General: (65) 6415-9433 | Fasimile: (65) 6538-4397
Tang Yeng Yuen
| Corporate Finance | Hong Leong Finance Limited
Co. Registration No.: 196100003D | www.hlf.com.sg
16 Raffles Quay #01-05 Hong Leong Building Singapore 048581
Direct: (65) 6415-9887 | General: (65) 6415-9433 | Fasimile: (65) 6538-4397
Lift trading should be 35 if not wrong, huat ah, hope next week Dow Jones rebound strong so resume trading also open big Big pop up
Bb in control, OEL, THAN THIS, NEXT TARGET for halt and announce good news, Asia phon?
Bid vol. 1 million alr. Lai liao
HUAT AH!!!!!
SmallSmall ( Date: 13-Mar-2020 11:08) Posted:
|
Halted for annoucement. Knowing this CHF, likely to be something positive realting to the Covid Testing or Mosquito Repellant. :)